TY  - GEN
AU  - Lawitz,Eric
AU  - Poordad,Fred
AU  - Wells,Jennifer
AU  - Hyland,Robert H
AU  - Yang,Yin
AU  - Dvory-Sobol,Hadas
AU  - Stamm,Luisa M
AU  - Brainard,Diana M
AU  - McHutchison,John G
AU  - Landaverde,Carmen
AU  - Gutierrez,Julio
TI  - Sofosbuvir-velpatasvir-voxilaprevir with or without ribavirin in direct-acting antiviral-experienced patients with genotype 1 hepatitis C virus
SN  - 1527-3350
PY  - 2017///0901
KW  - Adult
KW  - Aged
KW  - Aminoisobutyric Acids
KW  - Antiviral Agents
KW  - administration & dosage
KW  - Carbamates
KW  - Confidence Intervals
KW  - Cyclopropanes
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Drug Therapy, Combination
KW  - Female
KW  - Follow-Up Studies
KW  - Genotype
KW  - Hepacivirus
KW  - drug effects
KW  - Hepatitis C, Chronic
KW  - drug therapy
KW  - Heterocyclic Compounds, 4 or More Rings
KW  - Humans
KW  - Lactams, Macrocyclic
KW  - Leucine
KW  - analogs & derivatives
KW  - Macrocyclic Compounds
KW  - Male
KW  - Middle Aged
KW  - Proline
KW  - Prospective Studies
KW  - Quinoxalines
KW  - Ribavirin
KW  - Severity of Illness Index
KW  - Sofosbuvir
KW  - Sulfonamides
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1002/hep.29130
ER  -